Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Martis

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
Evaluation of short-chain polypeptides as an osmotic agent in continuous ambulatory peritoneal dialysis patientsA L Imholz, N Lameire, D Faict, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patientsB Pagliari, A Baretta, V De Cristofaro, et al.
The American Journal of Clinical Nutrition|May 1, 1985
Comparison of the elimination of 10 and 20% TRAVAMULSION lipid emulsion from the blood of beagle dogsR Cotter, L Martis, F Cosmas, et al.
Journal of Pharmaceutical Sciences|February 1, 1990
In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog modelR W Wood, L Martis, A W Gillum, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 2, 2001
Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamicsA Breborowicz, A Polubinska, K Pawlaczyk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
The use of peptides in peritoneal dialysis fluidsR T Krediet, A L Imholz, N Lameire, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1997
Alterations of intraperitoneal inflammation by the addition of L-2-oxothiazolidine-carboxylateK Korybalska, A Breborowicz, K Wieczorowska-Tobis, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Interactions of cells from peritoneal dialysate with mesothelial cells and fibroblasts in cultureA Breborowicz, E Balaskas, G D Oreopoulos, et al.
Toxicology and Applied Pharmacology|June 30, 1981
Influence of concentration and rate of intravenous administration on the toxicity of cyclohexanone in beagle dogsM T Koeferl, T R Miller, J D Fisher, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1984
Comparison of the elimination and metabolism of 10% Travamulsion and 10% Intralipid lipid emulsion in the dogR Cotter, L Martis, F Cosmas, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
Evaluation of short-chain polypeptides as an osmotic agent in continuous ambulatory peritoneal dialysis patientsA L Imholz, N Lameire, D Faict, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patientsB Pagliari, A Baretta, V De Cristofaro, et al.
The American Journal of Clinical Nutrition|May 1, 1985
Comparison of the elimination of 10 and 20% TRAVAMULSION lipid emulsion from the blood of beagle dogsR Cotter, L Martis, F Cosmas, et al.
Journal of Pharmaceutical Sciences|February 1, 1990
In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog modelR W Wood, L Martis, A W Gillum, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 2, 2001
Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamicsA Breborowicz, A Polubinska, K Pawlaczyk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
The use of peptides in peritoneal dialysis fluidsR T Krediet, A L Imholz, N Lameire, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1997
Alterations of intraperitoneal inflammation by the addition of L-2-oxothiazolidine-carboxylateK Korybalska, A Breborowicz, K Wieczorowska-Tobis, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Interactions of cells from peritoneal dialysate with mesothelial cells and fibroblasts in cultureA Breborowicz, E Balaskas, G D Oreopoulos, et al.
Toxicology and Applied Pharmacology|June 30, 1981
Influence of concentration and rate of intravenous administration on the toxicity of cyclohexanone in beagle dogsM T Koeferl, T R Miller, J D Fisher, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1984
Comparison of the elimination and metabolism of 10% Travamulsion and 10% Intralipid lipid emulsion in the dogR Cotter, L Martis, F Cosmas, et al.
Pageof 7